15-Sep-2026
Genius Sports Limited (GENI) Gets a Buy from Northland Securities
TipRanks (Mon, 14-Sep 11:25 AM ET)
Genius Sports: Americans are Going to Keep Wagering
Business Wire (Mon, 14-Sep 8:00 AM ET)
Genius Sports and Equativ Bring Live Sports Moment Targeting to StackAdapt
Business Wire (Thu, 10-Sep 8:00 AM ET)
Genius Sports and TelevisaUnivision to Launch New Era of Immersive Liga MX Broadcasts
Business Wire (Wed, 9-Sep 8:00 AM ET)
Business Wire (Tue, 8-Sep 4:05 PM ET)
Genius Sports Research Reveals the New Playbook for Multiscreen Sports Advertising
Business Wire (Mon, 31-Aug 8:00 AM ET)
GENI Raises Full-Year Outlook After Robust Q2 Performance—Margin and Revenue Growth Outpace Guidance
Market Chameleon (Thu, 6-Aug 3:50 AM ET)
Genius Sports Beats Second Quarter Guidance and Raises Full-Year Outlook
Business Wire (Thu, 6-Aug 7:00 AM ET)
Genius Sports and Kalshi Strike Major Official Data, Media and Integrity Partnership
Business Wire (Wed, 5-Aug 8:00 AM ET)
Market Chameleon (Tue, 4-Aug 4:30 AM ET)
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.
Genius Sports trades on the NYSE stock market under the symbol GENI.
As of September 15, 2026, GENI stock price declined to $6.56 with 4,883,190 million shares trading.
GENI has a beta of 2.09, meaning it tends to be more sensitive to market movements. GENI has a correlation of 0.14 to the broad based SPY ETF.
GENI has a market cap of $1.75 billion. This is considered a Small Cap stock.
Last quarter Genius Sports reported $196 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $11 million and missed earnings estimates by -$.29.
In the last 3 years, GENI traded as high as $13.73 and as low as $3.83.
The top ETF exchange traded funds that GENI belongs to (by Net Assets): WCMI, ARKW, VTWO, BETZ, VTWV.
GENI has underperformed the market in the last year with a price return of -47.4% while the SPY ETF gained +15.7%. GENI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.5% and -8.6%, respectively, while the SPY returned +0.6% and -0.6%, respectively.
GENI support price is $6.56 and resistance is $7.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GENI shares will trade within this expected range on the day.